1. Home
  2. IRWD vs RSSS Comparison

IRWD vs RSSS Comparison

Compare IRWD & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • RSSS
  • Stock Information
  • Founded
  • IRWD 1998
  • RSSS 2006
  • Country
  • IRWD United States
  • RSSS United States
  • Employees
  • IRWD N/A
  • RSSS N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • RSSS Business Services
  • Sector
  • IRWD Health Care
  • RSSS Consumer Discretionary
  • Exchange
  • IRWD Nasdaq
  • RSSS Nasdaq
  • Market Cap
  • IRWD 97.4M
  • RSSS 90.6M
  • IPO Year
  • IRWD 2010
  • RSSS N/A
  • Fundamental
  • Price
  • IRWD $0.71
  • RSSS $2.69
  • Analyst Decision
  • IRWD Buy
  • RSSS
  • Analyst Count
  • IRWD 5
  • RSSS 0
  • Target Price
  • IRWD $4.94
  • RSSS N/A
  • AVG Volume (30 Days)
  • IRWD 3.2M
  • RSSS 43.1K
  • Earning Date
  • IRWD 08-07-2025
  • RSSS 05-08-2025
  • Dividend Yield
  • IRWD N/A
  • RSSS N/A
  • EPS Growth
  • IRWD N/A
  • RSSS N/A
  • EPS
  • IRWD N/A
  • RSSS N/A
  • Revenue
  • IRWD $317,676,000.00
  • RSSS $48,753,578.00
  • Revenue This Year
  • IRWD N/A
  • RSSS $12.42
  • Revenue Next Year
  • IRWD N/A
  • RSSS $7.47
  • P/E Ratio
  • IRWD N/A
  • RSSS N/A
  • Revenue Growth
  • IRWD N/A
  • RSSS 14.85
  • 52 Week Low
  • IRWD $0.53
  • RSSS $2.32
  • 52 Week High
  • IRWD $7.11
  • RSSS $4.24
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 51.76
  • RSSS 44.29
  • Support Level
  • IRWD $0.62
  • RSSS $2.60
  • Resistance Level
  • IRWD $0.74
  • RSSS $2.99
  • Average True Range (ATR)
  • IRWD 0.08
  • RSSS 0.14
  • MACD
  • IRWD 0.02
  • RSSS -0.01
  • Stochastic Oscillator
  • IRWD 52.24
  • RSSS 23.08

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

Share on Social Networks: